These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39366532)

  • 1. SNRPB2 in the pan-cancer landscape: A bioinformatics exploration and validation in hepatocellular carcinoma.
    Li B; Liu J; Huang L; Cai J; Guo L; Xu L; Xu Q; Liu J; Huang J; Hu W; Tang X; Liu Z; Liu T
    Cell Signal; 2024 Dec; 124():111445. PubMed ID: 39366532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the oncogenic potential of ADAM9 in hepatocellular carcinoma through bioinformatics and experimental approaches.
    Jiang L; Huang W; Cao M; Jiang Y; Li S; Li M; Yang R; Wu Z; Wang Y; Lv C; Huang Z
    Sci Rep; 2024 Nov; 14(1):26432. PubMed ID: 39488509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
    Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
    Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
    Cai J; Zhou M; Xu J
    World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.
    Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP
    Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study.
    Zhu W; Fu M; Li Q; Chen X; Liu Y; Li X; Luo N; Tang W; Zhang Q; Yang F; Chen Z; Zhang Y; Peng B; Zhang Q; Zhang Y; Peng X; Hu G
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113253. PubMed ID: 39353384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pan-cancer study of ADAM9's immunological function and prognostic value particularly in liver cancer.
    AmeliMojarad M; AmeliMojarad M; Wang J; Tavakolpour V; Shariati P
    Sci Rep; 2024 Nov; 14(1):26862. PubMed ID: 39505907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.
    Pan B; Cheng J; Tan W; Wu X; Fan Q; Fan L; Jiang M; Yu R; Cheng X; Deng Y
    Aging (Albany NY); 2024 May; 16(9):8171-8197. PubMed ID: 38738999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
    Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
    Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-driven lncRNA CTD-2510F5.4: a potential player in hepatocellular carcinoma's prognostic stratification, cellular behavior, tumor microenvironment, and therapeutic response.
    Abulihaiti Z; Li W; Yang L; Zhang H; Du A; Tang N; Lu Y; Zeng J
    Mol Biol Rep; 2024 Aug; 51(1):905. PubMed ID: 39133347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKL3 is a promising biomarker for diagnosis and prognosis prediction in patients with hepatocellular carcinoma.
    Wu Q; Lu M; Ouyang H; Zhou T; Lei J; Wang P; Wang W
    Exp Biol Med (Maywood); 2024; 249():10106. PubMed ID: 38993199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma.
    Li C; Zhang ED; Ye Y; Xiao Z; Huang H; Zeng Z
    Sci Rep; 2024 Jun; 14(1):14051. PubMed ID: 38890507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLO1 regulates hepatocellular carcinoma proliferation and migration through the cell cycle pathway.
    Zhang Y; Tang X; Liu L; Cai D; Gou S; Hao S; Li Y; Shen J; Chen Y; Zhao Y; Wu X; Li M; Chen M; Li X; Sun Y; Gu L; Li W; Wang F; Zhang Z; Wang X; Deng S; Xiao Z; Yao L; Du F
    BMC Cancer; 2024 Oct; 24(1):1297. PubMed ID: 39434012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive prognostic and immunological analysis of Cullin2 in pan-cancer and its identification in hepatocellular carcinoma.
    Jia L; Zhang X; Zhou T; Xie J; Jin J; Zhang D; Zhu C; Wan R
    Aging (Albany NY); 2024 May; 16(10):8898-8921. PubMed ID: 38787355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
    Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 18. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.
    Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q
    J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the influence of AP1M2 in modulating hepatocellular carcinoma growth and Mobility through JNK/ErK signaling pathway control.
    Wang H; Xie X; Du M; Wang X; Wang K; Chen X; Yang H
    Gene; 2025 Jan; 933():148955. PubMed ID: 39303819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
    Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
    Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.